Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Sessa

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
Stroke|June 2, 2016
Clinical Pregenetic Screening for Stroke Monogenic Diseases: Results From Lombardia GENS RegistryAnna Bersano, Hugh Stephen Markus, Silvana Quaglini, et al.
Journal of Neurology|December 22, 2023
Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS RegistryPietro Iaffaldano, Giuseppe Lucisano, Tommaso Guerra, et al.
Nature Genetics|November 25, 2014
Common variation in PHACTR1 is associated with susceptibility to cervical artery dissectionStéphanie Debette, Yoichiro Kamatani, Tiina M Metso, et al.
Journal of Neurology|December 3, 2014
Intravenous thrombolysis or endovascular therapy for acute ischemic stroke associated with cervical internal carotid artery occlusion: the ICARO-3 studyMaurizio Paciaroni, Domenico Inzitari, Giancarlo Agnelli, et al.
European Stroke Journal|March 29, 2026
Effectiveness and safety of endovascular therapy compared to intravenous thrombolysis in acute ischaemic stroke due to medium-vessel occlusions: a real-world multicentre study from the Italian SITS registryMatteo Farè, Elisa Bianchi, Giulia Benina, et al.
European Journal of Neurology|July 15, 2025
Effects of GBA1 Variants in Patients With Parkinson's Disease and Levodopa-Carbidopa Intestinal Gel: A Nation-Wide, Multicenter, Longitudinal, "Real-World" Study. The EPIC StudyRoberto Cilia, Fabiana Colucci, Emanuele Cereda, et al.
JAMA Network Open|April 28, 2026
Continuation vs Switching Direct Oral Anticoagulant Therapy After Breakthrough StrokeLucio D'Anna, Francesca Gabriele, Raffaele Ornello, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|June 19, 2026
Early versus Late starting of Direct Oral Anticoagulants after breakthrough ischemic stroke: A Target Trial Analysis from the ASPERA-R StudyLucio D'Anna, Matteo Foschi, Francesca Gabriele, et al.
European Stroke Journal|February 27, 2026
Impact of cancer on outcomes following breakthrough ischaemic stroke on oral anticoagulants for atrial fibrillation: insights from the ASPERA-R studyMatteo Foschi, Federico De Santis, Francesca Gabriele, et al.
Journal of the American Heart Association|March 31, 2026
Sex Differences in Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants for Atrial Fibrillation: An ASPERA-R Inverse Probability Weighted AnalysisMatteo Foschi, Lucio D'Anna, Francesca Gabriele, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Stroke|June 2, 2016
Clinical Pregenetic Screening for Stroke Monogenic Diseases: Results From Lombardia GENS RegistryAnna Bersano, Hugh Stephen Markus, Silvana Quaglini, et al.
Journal of Neurology|December 22, 2023
Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS RegistryPietro Iaffaldano, Giuseppe Lucisano, Tommaso Guerra, et al.
Nature Genetics|November 25, 2014
Common variation in PHACTR1 is associated with susceptibility to cervical artery dissectionStéphanie Debette, Yoichiro Kamatani, Tiina M Metso, et al.
Journal of Neurology|December 3, 2014
Intravenous thrombolysis or endovascular therapy for acute ischemic stroke associated with cervical internal carotid artery occlusion: the ICARO-3 studyMaurizio Paciaroni, Domenico Inzitari, Giancarlo Agnelli, et al.
European Stroke Journal|March 29, 2026
Effectiveness and safety of endovascular therapy compared to intravenous thrombolysis in acute ischaemic stroke due to medium-vessel occlusions: a real-world multicentre study from the Italian SITS registryMatteo Farè, Elisa Bianchi, Giulia Benina, et al.
European Journal of Neurology|July 15, 2025
Effects of GBA1 Variants in Patients With Parkinson's Disease and Levodopa-Carbidopa Intestinal Gel: A Nation-Wide, Multicenter, Longitudinal, "Real-World" Study. The EPIC StudyRoberto Cilia, Fabiana Colucci, Emanuele Cereda, et al.
JAMA Network Open|April 28, 2026
Continuation vs Switching Direct Oral Anticoagulant Therapy After Breakthrough StrokeLucio D'Anna, Francesca Gabriele, Raffaele Ornello, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|June 19, 2026
Early versus Late starting of Direct Oral Anticoagulants after breakthrough ischemic stroke: A Target Trial Analysis from the ASPERA-R StudyLucio D'Anna, Matteo Foschi, Francesca Gabriele, et al.
European Stroke Journal|February 27, 2026
Impact of cancer on outcomes following breakthrough ischaemic stroke on oral anticoagulants for atrial fibrillation: insights from the ASPERA-R studyMatteo Foschi, Federico De Santis, Francesca Gabriele, et al.
Journal of the American Heart Association|March 31, 2026
Sex Differences in Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants for Atrial Fibrillation: An ASPERA-R Inverse Probability Weighted AnalysisMatteo Foschi, Lucio D'Anna, Francesca Gabriele, et al.
Pageof 13